Chen Lu-lu, Deng Xiang-qun, Li Ning-xu
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan 430022, China.
Zhonghua Yi Xue Za Zhi. 2007 May 29;87(20):1434-7.
To investigate the molecular mechanisms of calorie restriction (CR) in treatment of nonalcoholic fatty liver disease (NAFLD).
25 male Wistar rats were randomly divided into 2 groups: normal control group (NC, n = 7) fed with regular diet and high fat diet-NAFLD model group (HFM, n = 18) fed with high-fat diet. Two months later, the rats in Group HFM were further divided into 2 subgroups: continuous high-fat feeding group (HF, n = 9) and normal diet feeding with 60% calorie restriction group (CR, n = 9). The rats were sacrificed after 1 month calorie restriction. By the end of experiment, body weight (BW), visceral fat mass (VF), fasting plasma glucose (FPG), fasting serum insulin (FINS), blood lipids (BL), including total cholesterol (TC) and triglyceride (TG), and hepatoultrastructure changes were examined to evaluate the effect of different feeding protocols on the experimental animals. The mRNA expression of the longevity gene SIRT1 in the liver was detected by RT-PCR. Western blot analysis was performed to determine the expression of SIRT1 protein in each group.
Electron microscopy showed that the rats in group HF displayed obviously abnormal hepatoultrastructure, and the ultramicropathology changes of liver cell were improved obviously in Group CR. The VF, FINS, FPG, TC, and TG of the Group HF were 15.1 g +/- 4.1 g, 29.22 mU/L +/- 7.28 mU/L, 6.2 mmol/L +/- 1.46 mmol/L, 2.61 mmol/L +/- 0.29 mmol/L, and 1.35 mmol/L +/- 0.21 mmol/L respectively, all significantly higher than those in Group NC (9.0 g +/- 0.4 g, 13.09 mU/L +/- 1.18 mU/L, 4.4 mmol/L +/- 0.57 mmol/L, 1.41 mmol/L +/- 0.28 mmol/L, and 0.67 mmol/L +/- 0.10 mmol/L respectively, all P < 0.01). The mRNA expression of SIRT1 in the liver of Group HF was significantly lower than that of Group NC (P < 0.05), and the mRNA expression of SIRT1 in the liver of Group CR was significantly higher than those of Group HF and Group NC (both P < 0.01). The protein expression of SIRT1 of Group HF was significantly lower than that of Group NC (P < 0.01), and that of Group CR was significantly higher than that of Group HF, however, still significantly lower than that of Group NC (both P < 0.01). The BW and VF, FINS, FPG, TC, and TG of Group CR were all significantly lower than those of Group HF (all P < 0.01).
CR can reverse NAFLD significantly. The increased expression of SIRT1 in liver induced by CR may be an important molecular mechanism involved in the improvement of NAFLD by CR.
探讨热量限制(CR)治疗非酒精性脂肪性肝病(NAFLD)的分子机制。
将25只雄性Wistar大鼠随机分为2组:正常对照组(NC,n = 7)给予常规饮食,高脂饮食-NAFLD模型组(HFM,n = 18)给予高脂饮食。两个月后,HFM组大鼠进一步分为2个亚组:持续高脂喂养组(HF,n = 9)和60%热量限制的正常饮食喂养组(CR,n = 9)。热量限制1个月后处死大鼠。实验结束时,检测体重(BW)、内脏脂肪量(VF)、空腹血糖(FPG)、空腹血清胰岛素(FINS)、血脂(BL),包括总胆固醇(TC)和甘油三酯(TG),以及肝脏超微结构变化,以评估不同喂养方案对实验动物的影响。采用RT-PCR检测肝脏中长寿基因SIRT1的mRNA表达。进行蛋白质免疫印迹分析以确定每组中SIRT1蛋白的表达。
电子显微镜显示,HF组大鼠肝脏超微结构明显异常,而CR组肝细胞的超微病理学变化明显改善。HF组的VF、FINS、FPG、TC和TG分别为15.1 g±4.1 g、29.22 mU/L±7.28 mU/L、6.2 mmol/L±1.46 mmol/L、2.61 mmol/L±0.29 mmol/L和1.35 mmol/L±0.21 mmol/L,均显著高于NC组(分别为9.0 g±0.4 g、13.09 mU/L±1.18 mU/L、4.4 mmol/L±0.57 mmol/L、1.41 mmol/L±0.28 mmol/L和0.67 mmol/L±0.10 mmol/L,均P < 0.01)。HF组肝脏中SIRT1的mRNA表达显著低于NC组(P < 0.05),CR组肝脏中SIRT1的mRNA表达显著高于HF组和NC组(均P < 0.01)。HF组SIRT1的蛋白表达显著低于NC组(P < 0.01),CR组显著高于HF组,但仍显著低于NC组(均P < 0.01)。CR组的BW、VF、FINS、FPG、TC和TG均显著低于HF组(均P < 0.01)。
CR可显著逆转NAFLD。CR诱导肝脏中SIRT1表达增加可能是CR改善NAFLD的重要分子机制。